This study examines global COVID-19 vaccination efforts for older adults and uncovers striking gaps in access and inconsistencies in vaccination schedules. Study: Global landscape of COVID-19 vaccination programmes for older adults: a descriptive study . Image Credit: Shutterstock AI/Shutterstock.
com A recent study published in The Lancet provides a global overview of coronavirus disease 2019 (COVID-19) vaccination programs among the elderly. Achieving COVID-19 vaccine equity Despite the emergence of novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants, the World Health Organization (WHO) officially withdrew the status of ‘public health emergency’ from COVID-19 in May 2023. Vaccination has been instrumental in reducing the spread of SARS-CoV-2 and preventing severe disease in infected individuals.
Updated booster vaccine doses have been developed to ensure continued protection against novel viral variants, particularly in high-risk patient populations. Vaccine equity aims to distribute the most effective and variant-specific vaccines to eligible recipients rather than providing any available vaccine, as many COVID-19 vaccines are now ineffective against emerging SARS-CoV-2 variants and subvariants. Achieving vaccine equity requires continuous monitoring to update strategies that will expand access and uptake.
About the study Data for the study were obtained from public databases that provided information on the different types of vaccines used, vacc.
